Good question. I don't know. Personally, I think the NGIO call should have still gone through. A better update on the Peptides should have happened - more in-depth. Possibly a PR on the funding and several other things going on.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
